Two pivotal studies pave the way for tofacitinib (Xeljanz) in PsA: expert

Sponsored by Pfizer Australia Pty Ltd

In this short video Professor Oliver FitzGerald from the University College Dublin, Ireland, discusses the findings of two pivotal studies on the use of tofacitinib (Xeljanz) in patients with psoriatic arthritis.

Already a member?

Login to keep reading.

© 2021 the limbic